These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37706110)

  • 41. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.
    Kiyosawa K; Sodeyama T; Tanaka E; Gibo Y; Yoshizawa K; Nakano Y; Furuta S; Akahane Y; Nishioka K; Purcell RH
    Hepatology; 1990 Oct; 12(4 Pt 1):671-5. PubMed ID: 2170265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B virus replication in Chinese patients with hepatocellular carcinoma.
    Lok AS; Ma OC
    Hepatology; 1990 Sep; 12(3 Pt 1):582-8. PubMed ID: 2169455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis D virus dual infection increased the risk of hepatocellular carcinoma compared with hepatitis B virus mono infection: A meta-analysis.
    Chang TE; Su CW; Huang YS; Huang YH; Hou MC; Wu JC
    J Chin Med Assoc; 2022 Jan; 85(1):30-41. PubMed ID: 35006125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis delta virus epigenetically enhances clusterin expression via histone acetylation in human hepatocellular carcinoma cells.
    Liao FT; Lee YJ; Ko JL; Tsai CC; Tseng CJ; Sheu GT
    J Gen Virol; 2009 May; 90(Pt 5):1124-1134. PubMed ID: 19264665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection: a study from Kure, Japan.
    Tamura I; Kurimura O; Koda T; Ichimura H; Katayama S; Kurimura T; Inaba Y
    J Gastroenterol Hepatol; 1993; 8(5):433-6. PubMed ID: 8218990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New actors come into play against hepatitis delta.
    Riveiro-Barciela M; Palom A; Buti M
    Rev Esp Enferm Dig; 2022 Dec; 114(12):702-704. PubMed ID: 36043543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
    Alfaiate D; Clément S; Gomes D; Goossens N; Negro F
    J Hepatol; 2020 Sep; 73(3):533-539. PubMed ID: 32151618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy.
    Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; George J; Zekry A; Maher L
    J Clin Nurs; 2018 Jul; 27(13-14):2673-2683. PubMed ID: 29603817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between hepatitis B virus/hepatitis C virus infection and primary hepatocellular carcinoma risk: A meta-analysis based on Chinese population.
    Li L; Lan X
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C284-C287. PubMed ID: 28230038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical and etiologic features of hepatocarcinoma in Sicily].
    Carroccio A; Soresi M; Bonfissuto G; Magliarisi C; Anastasi G; Vuturo O; Notarbartolo A; Montalto G
    Ann Ital Med Int; 1999; 14(4):233-8. PubMed ID: 10638015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic infection with hepatitis G virus in relation to hepatocellular carcinoma among non-Asians in Los Angeles County, California.
    Yuan JM; Govindarajan S; Ross RK; Yu MC
    Cancer; 1999 Sep; 86(6):936-43. PubMed ID: 10491518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C virus and hepatocellular carcinoma.
    Kew MC
    FEMS Microbiol Rev; 1994 Jul; 14(3):211-9. PubMed ID: 8086196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma.
    Ji J; Sundquist K; Sundquist J
    J Natl Cancer Inst; 2012 May; 104(10):790-2. PubMed ID: 22423008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus.
    Marion PL; Van Davelaar MJ; Knight SS; Salazar FH; Garcia G; Popper H; Robinson WS
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4543-6. PubMed ID: 3012572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T1653 mutation in the enhancer II region of the hepatitis B virus genome in southern African Blacks with hepatocellular carcinoma.
    Welschinger R; Kew MC; Viana R; Badri M
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):541-5. PubMed ID: 20173647
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delta agent and the etiology of hepatocellular carcinoma.
    Trichopoulos D; Day NE; Tzonou A; Hadziyannis S; Kaklamani E; Sparos L; Muñoz N; Hatzakis A
    Int J Cancer; 1987 Mar; 39(3):283-6. PubMed ID: 3028967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nucleos(t)ide analogues and Hepatitis B virus-related hepatocellular carcinoma: A literature review.
    Abd El Aziz MA; Sacco R; Facciorusso A
    Antivir Chem Chemother; 2020; 28():2040206620921331. PubMed ID: 32418480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan.
    Mumtaz K; Hamid SS; Adil S; Afaq A; Islam M; Abid S; Shah HA; Jafri W
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1503-7. PubMed ID: 16174065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analyses.
    Zhou X; Zhu HQ; Lu J
    Int J Clin Exp Med; 2014; 7(11):4038-50. PubMed ID: 25550913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
    Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.